News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

Sale of our Limoges Botanical Actives and In Vitro Diagnostics activities to Solabia

SEQENS today announced the sale of its Botanical Actives and In Vitro Diagnostics (“IVD”) activities located in Limoges (France) to Solabia, a global player specializing in high‑value natural ingredients for personal care, life sciences and diagnostics applications.

Nitrosamines: quick mobilization of a multidisciplinary team in response to regulatory changes

Our products contribute to the 17 United Nations SDGs

Improving customer service: a challenge for SEQENS group

Products & Technologies

The digitalisation of the maintenance function to better serve our customers

The Regulatory Affairs Team at Seqens: its strategic status for the Group and its customers

Analysis of hand sanitizers: SEQENS Bourgoin-Jallieu’s Quality Control Laboratory relies on Infra-Red technology

Press kit : Safety is at the heart of our activities

New collaboration between SEQENS and RONDOL

Products & Technologies

Flow Chemistry: an innovation to secure the Electronics supply-chain

Faced with the pandemic, the mobilization of the Seqens group’s quality and regulatory teams is essential

Risk management: the human factor

Continuous training to strengthen the quality culture

1 … 3 4 5 6

Contact